Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.

Eitemau Tebyg

• Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
  gan: Meyer, J, et al.
  Cyhoeddwyd: (2013)
• Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
  gan: Harris, S, et al.
  Cyhoeddwyd: (2011)
• A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
  gan: Rowland, R, et al.
  Cyhoeddwyd: (2012)
• Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
  gan: Pathan, A, et al.
  Cyhoeddwyd: (2012)
• Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
  gan: Pathan, A, et al.
  Cyhoeddwyd: (2012)